Your browser doesn't support javascript.
loading
Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies.
Kadam, Esha; Javaid, Mahnoor; Sen, Parikshit; Saha, Sreoshy; Ziade, Nelly; Day, Jessica; Wincup, Chris; Andreoli, Laura; Parodis, Ioannis; Tan, Ai Lyn; Shinjo, Samuel Katsuyuki; Dey, Dzifa; Cavagna, Lorenzo; Chatterjee, Tulika; Knitza, Johannes; Wang, Guochun; Dalbeth, Nicola; Velikova, Tsvetelina; Battista, Simone; Cheng, Karen; Boyd, Peter; Kobert, Linda; Gracia-Ramos, Abraham Edgar; Mittal, Srijan; Makol, Ashima; Gutiérrez, Carlos Enrique Toro; Uribe, Carlo V Caballero; Kuwana, Masataka; Burmester, Gerd-Rüdiger; Guillemin, Francis; Nikiphorou, Elena; Chinoy, Hector; Aggarwal, Vikas; Gupta, Latika.
Afiliación
  • Kadam E; Seth Gordhandhas Sunderdas Medical College and King Edwards Memorial Hospital, Mumbai, Maharashtra, India.
  • Javaid M; Medical College, Aga Khan University, Karachi, Pakistan.
  • Sen P; Maulana Azad Medical College, 2-Bahadurshah Zafar Marg, New Delhi, Delhi, 110002, India.
  • Saha S; Mymensingh Medical College, Mymensingh, Bangladesh.
  • Ziade N; Rheumatology Department, Saint-Joseph University, Beirut, Lebanon.
  • Day J; Rheumatology Department, Hotel-Dieu de France Hospital, Beirut, Lebanon.
  • Wincup C; Department of Rheumatology, Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.
  • Andreoli L; Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
  • Parodis I; Department of Medical Biology, University of Melbourne, Parkville, VIC, 3052, Australia.
  • Tan AL; Department of Rheumatology, King's College Hospital, London, UK.
  • Shinjo SK; Rheumatology and Clinical Immunology Unit, ASST Spedali Civili and University of Brescia, 25123, Brescia, Italy.
  • Dey D; Department of Clinical and Experimental Sciences, University of Brescia, 25123, Brescia, Italy.
  • Cavagna L; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
  • Chatterjee T; Department of Rheumatology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Knitza J; NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals Trust, Leeds, UK.
  • Wang G; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
  • Dalbeth N; Division of Rheumatology, Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo, SP, Brazil.
  • Velikova T; Department of Medicine and Therapeutics, School of Medicine and Dentistry, University of Ghana, College of Health Sciences, Korle-Bu, Accra, Ghana.
  • Battista S; Rheumatology Unit, Dipartimento di Medicine Interna e Terapia Medica, Università degli Studi di Pavia, Pavia, Lombardy, Italy.
  • Cheng K; Department of Internal Medicine, University of Illinois College of Medicine at Peoria, Peoria, IL, USA.
  • Boyd P; Medizinische Klinik 3, Rheumatologie Und Immunologie, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Ulmenweg 18, 91054, Erlangen, Deutschland.
  • Kobert L; Department of Rheumatology, China-Japan Friendship Hospital, Yinghua East Road, Chaoyang District, Beijing, 100029, China.
  • Gracia-Ramos AE; Department of Medicine, University of Auckland, Auckland, New Zealand.
  • Mittal S; Medical Faculty, Sofia University, St. Kliment Ohridski, 1 Kozyak Str., 1407, Sofia, Bulgaria.
  • Makol A; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, Campus of Savona, University of Genova, Savona, Italy.
  • Gutiérrez CET; Patient Research Partner/Volunteer, Myositis Support and Understanding, Lincoln, USA.
  • Uribe CVC; Services Support Officer, Arthritis Ireland, Dublin, Ireland.
  • Kuwana M; Chair, EULAR PARE Committee, Kilchberg, Switzerland.
  • Burmester GR; Research and Communications Specialist, The Myositis Association, Lincoln, USA.
  • Guillemin F; Department of Internal Medicine, National Medical Center "La Raza", Instituto Mexicano del Seguro Social, General Hospital, Av. Jacaranda S/N, Col. La Raza, Del. Azcapotzalco, C.P. 02990, Mexico City, Mexico.
  • Nikiphorou E; Maulana Azad Medical College, 2-Bahadurshah Zafar Marg, New Delhi, Delhi, 110002, India.
  • Chinoy H; Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.
  • Aggarwal V; Reference Center for Osteoporosis, Rheumatology and Dermatology, Pontificia Universidad Javeriana Cali, Columbia, USA.
  • Gupta L; Department of Medicine, Hospital Universidad del Norte, Barranquilla, Atlantico, Colombia.
Rheumatol Int ; 44(7): 1233-1244, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38609655
ABSTRACT

INTRODUCTION:

The growing recognition of holistic patient care highlights the various factors shaping the quality of life of individuals with autoimmune and rheumatic diseases (AIRDs). Beyond the traditional disease measures, there is an emerging acknowledgment of the less-explored aspects, including subjective well-being, social determinants of health, comorbidities, mental health, and medication adherence. Moreover, digital health services have empowered patients to engage actively in decision-making alongside clinicians. To explore these domains within the context of AIRDs, the "Collating the Voice of People with Autoimmune Diseases" COVAD survey was conceived, a successor of the previous two COVAD surveys. In this document, we present the study protocol in comprehensive detail.

METHODS:

The COVAD-3 survey is a cross-sectional patient self-reported e-survey incorporating multiple widely accepted scales/scores to assess various aspects of patients' lifestyles objectively. To ensure the survey's accuracy and usability across diverse regions, it will be translated into multiple languages and subjected to rigorous vetting and pilot testing. It will be distributed by collaborators via online platforms and data will be collected from patients with AIRDs, and healthy individuals over eight months. Data analysis will focus on outcome measures related to various social, demographic, economic, and psychological factors.

CONCLUSION:

With the increasing awareness to adopt a holistic treatment approach encompassing all avenues of life, the COVAD-3 survey aims to gain valuable insights into the impact of social, demographic, economic, and psychological determinants of health on the subjective well-being in patients with AIRDs, which will contribute to a better understanding of their overall health and well-being.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Enfermedades Autoinmunes Límite: Humans Idioma: En Revista: Rheumatol Int Año: 2024 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Enfermedades Autoinmunes Límite: Humans Idioma: En Revista: Rheumatol Int Año: 2024 Tipo del documento: Article País de afiliación: India